510(k) · Cleared
ClearedFinesse Personal Insulin Delivery Patch, Model FG-2000
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Calibra Medical, Inc. · OPP Pump, Infusion, Insulin Bolus
Cleared on Jan 20, 2010 as substantially equivalent to K053563 (Eli Lilly and Company, 2006) and 1 other predicate after a 112-day review. Its family tree reaches back 2 generations to 2003. 6 later devices descend from it.
- Decided
- Jan 20, 2010
- Review
- 112 days
- Class
- Class II
- Product code
- OPP
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 2 generations to K031373 (2003). 4 ancestors in all, the oldest K010359 (2001). 6 later devices descend from it, 3 citing it directly.
- Root · 2 generations backK031373 Ixl Diabetes Management SystemInsulet Corp. · 2003
- 1 generation backK050971 Biovalve Insulin Delivery Systems (Bids)Biovalve Technologies, Inc. · 2005
- This deviceK093065 Finesse Personal Insulin Delivery Patch, Model FG-2000Calibra Medical, Inc. · 2010
- Descendant · cites it directly · 5 of its ownK100947 Finesse Personal Insulin Delivery Patch, Model FG 2000Calibra Medical, Inc. · 2010
- Descendant · cites it directly · 4 of its ownK111924 Finesse Personal Insulin Delivery PatchCalibra Medical, Inc. · 2012
- Descendant · 2 generations on · 3 of its ownK163357 OneTouch Via On-Demand Insulin Delivery SystemLifescan Europe, A Division of Cilag GmbH · 2017
- Descendant · 2 generations on · 2 of its ownK233447 CeQur Simplicity™ On-Demand Insulin Delivery SystemCequr SA · 2024
- Descendant · cites it directly · 1 of its ownK243273 CeQur Simplicity™ On-Demand Insulin Delivery SystemCequr SA · 2024
Showing 5 of 6 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 6 · See all- K100947Finesse Personal Insulin Delivery Patch, Model FG 2000Calibra Medical, Inc. · 2010 · cites it directly5descendants
- K111924Finesse Personal Insulin Delivery PatchCalibra Medical, Inc. · 2012 · cites it directly4descendants
- K163357OneTouch Via On-Demand Insulin Delivery SystemLifescan Europe, A Division of Cilag GmbH · 2017 · 2 generations on3descendants
- K233447CeQur Simplicity™ On-Demand Insulin Delivery SystemCequr SA · 2024 · 2 generations on2descendants
- K243273CeQur Simplicity™ On-Demand Insulin Delivery SystemCequr SA · 2024 · cites it directly1descendant
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K031373 | Ixl Diabetes Management System | Insulet Corp. | 2003 | — |
| −1 | K050971 | Biovalve Insulin Delivery Systems (Bids) | Biovalve Technologies, Inc. | 2005 | — |
| 0 (this device) | K093065 | Finesse Personal Insulin Delivery Patch, Model FG-2000 | Calibra Medical, Inc. | 2010 | — |
| +1 | K100947 | Finesse Personal Insulin Delivery Patch, Model FG 2000 | Calibra Medical, Inc. | 2010 | — |
| +1 | K111924 | Finesse Personal Insulin Delivery Patch | Calibra Medical, Inc. | 2012 | — |
| +2 | K163357 | OneTouch Via On-Demand Insulin Delivery System | Lifescan Europe, A Division of Cilag GmbH | 2017 | — |
| +2 | K233447 | CeQur Simplicity™ On-Demand Insulin Delivery System | Cequr SA | 2024 | — |
| +1 | K243273 | CeQur Simplicity™ On-Demand Insulin Delivery System | Cequr SA | 2024 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2001 | 1 | 0 |
| 2006 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2010 | 1 | 0 |
| 2012 | 1 | 0 |
| 2017 | 1 | 0 |
| 2024 | 2 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in OPP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new OPP device
- #1 K233447 CeQur Simplicity™ On-Demand Insulin Delivery…score 14.2 · 6 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K053563 | Humapen MemoirSummary page 2…Medical, Inc. believes that the System described inthis Submission is substantially equivalent to a combination of the Eli Lilly and Company HumaPen Memoir (K(053563) and the Biovalve Insulin Delivery System (K050971). 7. Device Description The Finesse Insulin Delivery System is… | 2006 |
| * | K050971 | Biovalve Insulin Delivery Systems (Bids)Summary page 2…s Submission is substantially equivalent to a combination of the Eli Lilly and Company HumaPen Memoir (K(053563) and the Biovalve Insulin Delivery System (K050971). 7. Device Description The Finesse Insulin Delivery System is a sterile, nonpyrogenic, single-use, external, disp… | 2005 |
What descends from it? (6)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 4.4 years on median.
- None of the 4 ancestors has a recall.
- Of its descendants, K100947 (Calibra Medical, Inc., 2010) has gone furthest, with 5 descendants of its own.
How does its category compare?
All OPP devicesOPP Pump, Infusion, Insulin Bolus: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.
FDA decisions per year · OPP
2in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · OPP
Too few OPP 510(k)s in any year since 2007 to give a median.
Recalls per year · OPP
1in 2011
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · OPP
1in 2025
MAUDE reports naming product code OPP, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 2 | — | 0 | 0 |
| 2011 | 0 | — | 1 | 0 |
| 2012 | 1 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 22 |
| 2016 | 0 | — | 0 | 3 |
| 2017 | 1 | — | 0 | 6 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 2 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 1 |
| 2026 | 1 | — | 0 | — |
What is it indicated for?
The Finesse Insulin Delivery System is intended for subcutaneous,
bolus delivery of insulin for the management of diabetes mellitus in
persons requiring insulin.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K093065 · printed Nov 6, 2026
Cite this page
510(k) Report. “K093065: Finesse Personal Insulin Delivery Patch, Model FG-2000.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K093065
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026